Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: An acarbose and nateglinide comparative study

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Kato, Toru ^a   Inoue, Teruo ^b   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; GLUCOSE; INSULIN; NATEGLINIDE; ANTIDIABETIC AGENT; CYCLOHEXANE DERIVATIVE; DRUG DERIVATIVE; PHENYLALANINE;

AGED; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL TOLERANCE; OPEN STUDY; POSTPRANDIAL STATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TEST MEAL; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FOOD; LASER DOPPLER FLOWMETRY; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ACARBOSE; AGED; BLOOD GLUCOSE; BRACHIAL ARTERY; CYCLOHEXANES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; FOOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; PHENYLALANINE; VASODILATION;

EID: 77952267060     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-12     Document Type: Article

References (32)

1. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1994, 22:920-924.
2. DECODE Study Group, the European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001, 161:397-405. 10.1001/archinte.161.3.397, 11176766, DECODE Study Group, the European Diabetes Epidemiology Group.
3. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005, 111:363-368. 10.1161/01.CIR.0000153339.27064.14, 15668353.
4. Kato T, Inoue T, Morooka T, et al. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol 2006, 84:523-529.
5. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest 1994, 93:50-55. 10.1172/JCI116983, 293724, 8282821.
6. Lee IK, Kim HS, Bae JH. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia. Int J Clin Pract 2002, 129(suppl):59-64.
7. Higashi Y, Nakagawa K, Kimura M, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and non-dippers. J Am Coll Cardiol 2002, 40:2039-2043. 10.1016/S0735-1097(02)02535-4, 12475467.
8. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002, 346:1954-1962. 10.1056/NEJMoa013591, 12075056.
9. Tack CJ, Ong MK, Lutterman JA, et al. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance: effects of troglitazone. Diabetologia 1998, 41:569-576. 10.1007/s001250050948, 9628275.
10. Tooke JE, Goh KL. Vascular function in type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy. Diabet Med 1999, 16:710-715. 10.1046/j.1464-5491.1999.00099.x, 10510946.
11. Kawano H, Motoyama T, Hirashima O, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999, 34:146-154. 10.1016/S0735-1097(99)00168-0, 10400004.
12. Williams SB, Goldfine AB, Timimi FK, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998, 97:1695-1701.
13. Shige H, Ishikawa T, Suzukawa M, et al. Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus. Am J Cardiol 1999, 84:1272-1274. 10.1016/S0002-9149(99)00548-2, 10569346.
14. Hanefeld M, Cagatay M, Petrowitsch T, et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004, 25:10-16. 10.1016/S0195-668X(03)00468-8, 14683737.
15. Chiasson JL, Josse RG, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003, 290:486-494. 10.1001/jama.290.4.486, 12876091.
16. Ai M, Tanaka A, Ogita K, Shimokado K. Favorable effects of early insulin secretion by nateglinide on postprandial hyperlipidemia in patients with type 2 diabetes. Diabetes Care 2006, 29:1180. 10.2337/dc05-2336, 16644666.
17. Mari A, Gastaldelli A, Foley JE, et al. Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide. Diabetes Care 2005, 28:1132-1138. 10.2337/diacare.28.5.1132, 15855578.
18. Johnston PS, Lebovitz HE, Coniff RF, et al. Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrinol Metab 1998, 83:1515-1522. 10.1210/jc.83.5.1515, 9589648.
19. Shimabukuro M, Higa N, Chinen I, et al. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 2006, 91:837-842. 10.1210/jc.2005-1566, 16368744.
20. Shimabukuro M, Higa N, Takasu N, et al. A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in Type 2 diabetic patients. Diabet Med 2004, 21:983-986. 10.1111/j.1464-5491.2004.01272.x, 15317602.
21. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27:S5-10. 10.2337/diacare.27.2007.S5, 14693921, American Diabetes Association.
22. Harano Y, Miyawaki T, Nabiki S, et al. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J 2006, 53:173-180. 10.1507/endocrj.53.173, 16618974.
23. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972, 18:449-502.
25. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257-265. 10.1016/S0735-1097(01)01746-6, 11788217.
26. Inoue T, Matsuoka H, Higashi Y, et al. Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res 2008, 31:2105-2113. 10.1291/hypres.31.2105, 19139600.
27. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002, 106:1211-1218. 10.1161/01.CIR.0000027569.76671.A8, 12208795.
28. Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans sites and mechanism. Circulation 2002, 105:576-582. 10.1161/hc0502.103333, 11827922.
29. Cardillo C, Nambi SS, Kilcoyne CM, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999, 100:820-825.
30. Duerrschmidt N, Wippich N, Goettsch W, et al. Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biocham Biophys Res Commun 2000, 269:713-717.
31. Kashiwagi A, Shinozaki K, Nishio Y, et al. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 1999, 277:E976-E983.
32. Major-Pedersen A, Ihlemann N, Hermann TS, et al. Effects of acute and chronic attenuation of postprandial hyperglycemia on postglucose load endothelial function in insulin resistant individuals: is stimulation of first phase insulin secretion beneficial for the endothelial function?. Horm Metab Res 2008, 40:607-613. 10.1055/s-0028-1082327, 18792871.